← Back to Clinical Trials
Recruiting NCT06948162

NCT06948162 Exploration of the Utility of Dental-dedicated MRI for Dentistry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06948162
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Dental Crowding
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2025-03-14
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
dental-dedicated MRI (ddMRI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2025-03-14 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This description observational research is comparative in design, that is comparing existing standard clinical dental images, not obtained in this study, to test (i.e., ddMRI) images. The standard clinical dental images consist of radiographs, such as bitewings, periapical, panoramic, cone-beam CT, and medical CT, as well medical MRIs of the temporomandibular joints (TMJ).The conceptualization of research questions, study designing, and interpretation of imaging data has and will involve content expertise in all ddMRI research.

Eligibility Criteria

Inclusion Criteria: 1. Patient Age: 18 years old or older 2. Receiving imaging for routine dental care 3. Does not have a serious medical condition 4. Is not pregnant or is not potentially pregnant 5. Is willing and able to give consent in English 6. Has the ability to manage their own calendar and schedule appointments 7. Willing to have a separate 2-hour appointment to have an MRI Exclusion Criteria: 1. Unable to consent to participant in English 2. Serious health condition, which includes but not limited to renal failure/on dialysis, unstable heart disease (uncontrolled arrhythmia, cardiomyopathy and/or unable to lay flat, within 1 month of cardiac catheterization or myocardial infarction), unstable cerebral vascular disease (within 1 month of stroke and/or stent placement), diabetes (type I or II) not controlled by medication or diet, uncontrolled seizures, uncontrolled hyperthyroidism, non-allergic bronchospasm (chronic obstructive pulmonary disease and emphysema), uncontrolled movement disorder, and liver failure 3. Pregnant and/or intending to become pregnant, 4. Prisoner and/or not able to manage their own scheduling 5. Screen positive on MR safety questionnaire, specifically including people that have worked with or otherwise been exposure to metal particles and have the potential for such particles to be embed within them.

Contact & Investigator

Central Contact

Rania Nuwailati, BDS, MS, PhD

✉ Nuwai003@umn.edu

📞 612-626-8431

Principal Investigator

Donald R Nixdorf, DDS, MS

PRINCIPAL INVESTIGATOR

University of Minneosta

Frequently Asked Questions

Who can join the NCT06948162 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Crowding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06948162 currently recruiting?

Yes, NCT06948162 is actively recruiting participants. Contact the research team at Nuwai003@umn.edu for enrollment information.

Where is the NCT06948162 trial being conducted?

This trial is being conducted at Minneapolis, United States.

Who is sponsoring the NCT06948162 clinical trial?

NCT06948162 is sponsored by University of Minnesota. The principal investigator is Donald R Nixdorf, DDS, MS at University of Minneosta. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology